Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations - Related Studies

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

This study is ongoing, but not recruiting participants.

Study NCT00010452. Last updated on March 28, 2008. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphatic Malformations

2	Additional conditions recognized in this trial
		Congenital Abnormalities
		Lymphangioma, Cystic
		Lymphatic Abnormalities

3	More general conditions related to this trial
		Lymphangioma
		Lymphatic Diseases
		Lymphatic Vessel Tumors
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		picibanil

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		University of Iowa
		Chugai Pharmaceutical